Last updated on November 2019

Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain


Brief description of study

The study is a multicenter, open-label Phase 1b single dose escalation safety study for adult subjects with intractable pain associated with cancer in any area below the mid-thoracic level who meet all other eligibility criteria.

Detailed Study Description

All subjects who received RTX will be included in the analyses and summaries of safety, efficacy, PD, and PK assessments.

Clinical Study Identifier: NCT03226574

Find a site near you

Start Over